Last updated 2026-06-18
- Raised funding round, Jan 2019
Total raised
—
Last: 2019-01
Stage
Seed
Founded
2014
Headcount
6
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences
About
TaGeza Biopharmaceuticals is a biotechnology start-up dedicated to the study of cancer stem cells in the deadliest forms of cancer. The company seeks to identify central markers of highly aggressive cancer stem cells and develop drugs to target them, with the goal of eradicating different forms of treatment-resistant cancers. TaGeza is a spin-off company of Tel Hashomer Medical Research, Infrastructure and Services Ltd, the technology transfer arm of Sheba Medical Center.
Funding history · 1 round · — total
2019-01
Undisclosed
Q&A
- What is the primary focus of TaGeza Biopharmaceuticals?
- TaGeza Biopharmaceuticals is a biotechnology startup dedicated to the study of cancer stem cells in the deadliest forms of cancer. The company aims to identify central markers of highly aggressive cancer stem cells and develop drugs to target them.
- What is the current status of TaGeza Biopharmaceuticals?
- TaGeza Biopharmaceuticals is currently inactive, having ceased operations in September 2023.
- When was TaGeza Biopharmaceuticals founded?
- TaGeza Biopharmaceuticals was founded in February 2014.
- How many employees did TaGeza Biopharmaceuticals have?
- TaGeza Biopharmaceuticals had 1-10 employees.
- Which investor participated in TaGeza Biopharmaceuticals' funding round?
- aMoon Fund participated in TaGeza Biopharmaceuticals' funding round in January 2019.
- What is the company's current funding stage?
- TaGeza Biopharmaceuticals' current funding stage is Seed.
- What is the primary sector of TaGeza Biopharmaceuticals?
- The primary sector of TaGeza Biopharmaceuticals is Health Tech & Life Sciences.
- Who are the co-founders of TaGeza Biopharmaceuticals?
- The co-founders of TaGeza Biopharmaceuticals are Nadav Peles and Orit Harari-Steinberg.
Team · 2
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcareLaboratoriesPatients
Business model
B2B
Tags
drug-discoveryantibodiescancerbiopharmaceuticallaboratoriespharma-companies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2014-2 |
|---|---|
| Employees (exact) | 6 |
| Status reason | Non Active, Sep 2023 ceased to operate |